In:
Cancer Cytopathology, Wiley, Vol. 128, No. 5 ( 2020-05), p. 323-332
Abstract:
New Technologies for Cervical Cancer 2 is the first study in which the reproducibility of p16/Ki‐67 dual‐staining interpretation has been investigated in a large, unselected screening population positive for human papillomavirus and agreement both for adequacy and for positivity has been considered. The p16/Ki‐67 assay shows poor reproducibility for adequacy and good reproducibility for positivity comparable to that of cervical cytology. Nevertheless, the low reproducibility does not affect the sensitivity for cervical intraepithelial neoplasia 2+.
Type of Medium:
Online Resource
ISSN:
1934-662X
,
1934-6638
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Bookmarklink
